End-stage heart disease, high-risk research, and competence to consent: The case of the AbioCor artificial heart

Perspectives in Biology and Medicine

Volumn 49, Issue 1, 2006, Pages 19-34

  Morreim, E Haavi ^a  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL HEART; CARDIAC PATIENT; COMPETENCE; DEATH; DEVICE; HEART DISEASE; HEART FAILURE; HIGH RISK PATIENT; INFORMED CONSENT; MEDICAL DECISION MAKING; PRIORITY JOURNAL; RESEARCH ETHICS; REVIEW; TERMINAL CARE;

ATTITUDE TO DEATH; CHRONIC DISEASE; CLINICAL TRIALS; ETHICS, RESEARCH; HEART DISEASES; HEART, ARTIFICIAL; HUMANS; INFORMED CONSENT; MENTAL COMPETENCY; PATIENT PARTICIPATION; PATIENT SELECTION; RESEARCH SUBJECTS; TERMINAL CARE;

EID: 32444439145     PISSN: 00315982     EISSN: None     Source Type: Journal    
DOI: 10.1353/pbm.2006.0013     Document Type: Review

References (19)

1. Agrawal, M., and E. J. Emanuel. 2003. Ethics of phase 1 oncology studies: Reexamining the arguments and data. JAMA 290:1075-82.
2. Altman, L. K. How to assist failing hearts? New questions emerge. 2001. NY Times, Nov. 20.
3. Altman L. K. 2003. Doctors look for source of stent complications. NY Times, Nov. 18. http://www.nytimes.com/2003/11/18/health/policy/18DOCS.html.
4. Appelbaum, P. S., et al. 1987. False hopes and best data: Consent to research and the therapeutic misconception. Hastings Cent Rep 17(2):20-24.
5. Crouch, R. A., and C. Elliott. 1999. Moral agency and the family: The case of living related organ transplantation. Camb Q Healthc Ethics 8:275-87.
6. DeVries, W. C. 1988. The physician, the media, and the "spectacular" case. JAMA 259: 886-90.
7. In re Farrell, 529 A.2d 404, 415 (NJ.1987).
8. Fellner, C. H., and J. R. Marshall. 1970. Kidney donors: The myth of informed consent. Am J Psychiatry 126:1245-51.
9. Fox R. C., and J. P. Swazey. 2004. "He knows that machine is his mortality": Old and new social and cultural patterns in the clinical trial of the AbioCor artificial heart. Perspect Biol Med 47:74-99.
10. Frazier, O. H., et al. 2004. The total artificial heart: Where we stand. Cardiology 101:117-21.
11. Goodman v. United States, 298 F.3d 1048 (9th Cir 2002).
12. Hoffman, S. 1999. A proposal for federal legislation to address health insurance coverage for experimental and investigational treatments. Oregon Law Rev 78(1):203-74.
13. Katz, J. 1993. Human experimentation and human rights. St Louis Univ Law J 38:7-54.
14. Matter of Quintan, 355 A.2d 647 (N.J. 1976).
15. Mello, M. M., and T. A. Brennan. 2001. The controversy over high-dose chemotherapy with autologous bone marrow transplant for breast cancer. Health Aff 20(5):101-18.
16. Miller, M. 2000. Phase I cancer trials: A collusion of misunderstanding. Hastings Cent Rep 30(4):34-42.
17. Morreim, E. H. 2004. High-profile research and the media: The case of the AbioCor artificial heart. Hastings Cent Rep 34(1):11-24.
18. Pantilat, S. Z., and A. E. Steimle. 2004. Palliative care for patients with heart failure. JAMA 291:2476-82.
19. Spital, A. 2001. Ethical issues in living organ donation: Donor autonomy and beyond. Am J Kidney Dis 38:189-95.